• Login
    View Item 
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Nervous System Disorders
    • View Item
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Nervous System Disorders
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Longitudinal Changes in Parkinson’s Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study

    Thumbnail
    Date
    2021-08
    Author
    External author(s) only
    Metadata
    Show full item record
    Citation
    Liu, Y., Lawton, M.A., Lo, C., Bowring, F., Klein, J.C., Querejeta-Coma, A., Scotton, S., Welch, J., Razzaque, J., Barber, T., Ben-Shlomo, Y. and Hu, M.T. (2021), Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study. Mov Disord.
    Abstract
    Background: Parkinson’s disease (PD) comorbid with rapid eye movement sleep behavior disorder (RBD) may show more severe motor and non motor symptoms, suggesting a distinct PD subtype. Objective: The aim of this study was to investigate the impact of RBD on the longitudinal change of motor and non motor symptoms in patients with PD. Methods: Patients with early PD (diagnosed within 3.5 years) recruited from 2010 to 2019 were followed every 18 months in the Oxford Parkinson’s Disease Centre Discovery cohort. At each visit, we used standard questionnaires and measurements to assess demographic features and motor and non motor symptoms (including RBD, day-time sleepiness, mood, autonomic symptoms, cognition,and olfaction). Data were analyzed with linear mixed effects and Cox regression models. Possible RBD (pRBD) was longitudinally determined according to RBD Screening Questionnaire scores.Results: A total of 923 patients were recruited (mean age:67.1 9.59 years; 35.9% female), and 788 had follow-upassessment(s) (mean: 4.8  1.98 years, range: 1.3–8.3).Among them, 33.3% were identied as pRBD (PD + pRBD).Patients with PD + pRBD had more severe baseline symp-toms and showed faster progression on Movement Disorder Society-Unied Parkinson’s Disease Rating Scale parts I and III, Purdue Pegboard test, a nd Beck Depression Inventory scores. Moreover, PD + pRBD was associated with an increased level of risk for mild cognitive impairment (hazardratio [HR] = 1.36, 95% condence interval [CI]: 1.01–1.83),freezing of gait (HR = 1.42, 95% CI: 1.10–1.86), and frequent falling (HR = 1.62, 95% CI: 1.02–2.60).Conclusions: Patients with PD + pRBD progress fasteron motor, mood, and cognitive symptoms, confirming a more aggressive PD subtype that can be identified at baseline and has major clinical implications. © 2021 International Parkinson and Movement Disorder Society
    Description
    Available with an OpenAthens log in for eligible users
    URI
    https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/953
    Published online at:
    https://doi.org/10.1002/mds.28763
    Collections
    • Nervous System Disorders [22]

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc
     

     

    Browse

    All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsContributor Discipline

    My Account

    Login

    Researcher Profiles

    Researchers

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc